Revascularization of swine renal artery stenosis improves renal function but not the changes in vascular structure

Kidney International

Volumn 78, Issue 11, 2010, Pages 1110-1118

  Favreau, Frederic ^a,b,c,d   Zhu, Xiang Yang ^a   Krier, James D ^a   Lin, Jing ^a   Warner, Lizette ^a   Textor, Stephen C ^a   Lerman, Lilach O ^a  

^a MAYO CLINIC   (United States)

^b INSERM   (France)

^c UNIVERSITÉ DE POITIERS   (France)

^d POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

renal artery stenosis; renal hypertension; renovascular disease; revascularization

Indexed keywords

ANGIOGENIC FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION RATE; KIDNEY ARTERY STENOSIS; KIDNEY BLOOD FLOW; KIDNEY FIBROSIS; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVASCULARIZATION; SWINE; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM;

EID: 78349312725     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2010.142     Document Type: Article

References (30)

1. Garovic VD, Textor SC. Renovascular hypertension and ischemic nephropathy. Circulation 2005; 112: 1362-1374.
2. Textor SC, Lerman L, McKusick M. The uncertain value of renal artery interventions: where are we now? JACC Cardiovasc Interv 2009; 2: 175-182.
3. Dubel GJ, Murphy TP. The role of percutaneous revascularization for renal artery stenosis. Vasc Med 2008; 13: 141-156.
4. Textor SC. Ischemic nephropathy: where are we now? J Am Soc Nephrol 2004; 15: 1974-1982.
5. Chade AR, Zhu X, Mushin OP et al. Simvastatin promotes angiogenesis and prevents microvascular remodeling in chronic renal ischemia. FASEB J 2006; 20: 1706-1708.
6. Chade AR, Rodriguez-Porcel M, Grande JP et al. Distinct renal injury in early atherosclerosis and renovascular disease. Circulation 2002; 106: 1165-1171.
7. Chade AR, Rodriguez-Porcel M, Grande JP et al. Mechanisms of renal structural alterations in combined hypercholesterolemia and renal artery stenosis. Arterioscler Thromb Vasc Biol 2003; 23: 1295-1301.
8. Zhu XY, Chade AR, Rodriguez-Porcel M et al. Cortical microvascular remodeling in the stenotic kidney: role of increased oxidative stress. Arterioscler Thromb Vasc Biol 2004; 24: 1854-1859.
9. Lerman LO, Schwartz RS, Grande JP et al. Noninvasive evaluation of a novel swine model of renal artery stenosis. J Am Soc Nephrol 1999; 10: 1455-1465.
10. Chade AR, Zhu X, Lavi R et al. Endothelial progenitor cells restore renal function in chronic experimental renovascular disease. Circulation 2009; 119: 547-557.
11. Lerman LO, Nath KA, Rodriguez-Porcel M et al. Increased oxidative stress in experimental renovascular hypertension. Hypertension 2001; 37: 541-546.
12. Higashi Y, Sasaki S, Nakagawa K et al. Endothelial function and oxidative stress in renovascular hypertension. N Engl J Med 2002; 346: 1954-1962.
13. Airoldi F, Palatresi S, Marana I et al. Angioplasty of atherosclerotic and fibromuscular renal artery stenosis: time course and predicting factors of the effects on renal function. Am J Hypertens 2000; 13: 1210-1217.
14. Hansen KJ, Edwards MS, Craven TE et al. Prevalence of renovascular disease in the elderly: a population-based study. J Vasc Surg 2002; 36: 443-451.
15. Xia J, Seckin E, Xiang Y et al. Positron-emission tomography imaging of the angiotensin II subtype 1 receptor in swine renal artery stenosis. Hypertension 2008; 51: 466-473.
16. Lerman L, Textor SC. Pathophysiology of ischemic nephropathy. Urol Clin North Am 2001; 28: 793-803, ix.
17. Pipinos II, Nypaver TJ, Moshin SK et al. Response to angiotensin inhibition in rats with sustained renovascular hypertension correlates with response to removing renal artery stenosis. J Vasc Surg 1998; 28: 167-177.
18. Greene EL, Paller MS. Xanthine oxidase produces O2-. in posthypoxic injury of renal epithelial cells. Am J Physiol 1992; 263: F251-F255.
19. Cheung CM, Shurrab AE, Buckley DL et al. MR-derived renal morphology and renal function in patients with atherosclerotic renovascular disease. Kidney Int 2006; 69: 715-722.
20. Griffioen AW, Molema G. Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol Rev 2000; 52: 237-268.
21. Fischer C, Mazzone M, Jonckx B et al. FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy? Nat Rev Cancer 2008, 8, 942-956.
22. Baffert F, Le T, Thurston G et al. Angiopoietin-1 decreases plasma leakage by reducing number and size of endothelial gaps in venules. Am J Physiol Heart Circ Physiol 2006; 290: H107-H118.
23. Jackson C. Matrix metalloproteinases and angiogenesis. Curr Opin Nephrol Hypertens 2002; 11: 295-299.
24. Birrer M, Do DD, Mahler F et al. Treatment of renal artery fibromuscular dysplasia with balloon angioplasty: a prospective follow-up study. Eur J Vasc Endovasc Surg 2002; 23: 146-152.
25. Chade AR, Rodriguez-Porcel M, Herrmann J et al. Antioxidant intervention blunts renal injury in experimental renovascular disease. J Am Soc Nephrol 2004; 15: 958-966.
26. Chade AR, Krier JD, Rodriguez-Porcel M et al. Comparison of acute and chronic antioxidant interventions in experimental renovascular disease. Am J Physiol Renal Physiol 2004; 286: F1079-F1086.
27. Chade AR, Bentley MD, Zhu X et al. Antioxidant intervention prevents renal neovascularization in hypercholesterolemic pigs. J Am Soc Nephrol 2004; 15: 1816-1825.
28. Daghini E, Primak AN, Chade AR et al. Assessment of renal hemodynamics and function in pigs with 64-section multidetector CT: comparison with electron-beam CT. Radiology 2007; 243: 405-412.
29. Zhu XY, Rodriguez-Porcel M, Bentley MD et al. Antioxidant intervention attenuates myocardial neovascularization in hypercholesterolemia. Circulation 2004; 109: 2109-2115.
30. Dixon IM, Hao J, Reid NL et al. Effect of chronic AT(1) receptor blockade on cardiac Smad overexpression in hereditary cardiomyopathic hamsters. Cardiovasc Res 2000; 46: 286-297.